India to Cuba: Cyclophosphamide Export Trade Route

The India to Cuba Cyclophosphamide corridor is one of India's established pharmaceutical export routes, with 8 shipments documented worth a combined $105.8K USD. The route is dominated by BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED, which alone accounts for roughly 58% of all export value, reflecting the consolidated nature of India's cyclophosphamide manufacturing sector.

Across 4 active suppliers, the average shipment value stands at $13.2K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 78% of all shipments, consistent with cyclophosphamide's non-urgent bulk-order profile.

Shipment activity peaks during April–June, with an average transit time of 22 days port-to-port. The route has recorded an annual growth rate of 15.6%, placing it at rank #16 among India's top cyclophosphamide export destinations globally.

On the import side, key buyers of Indian cyclophosphamide in Cuba include MEDICUBA S A, MEDSA, MEDSA and 3 others. MEDICUBA S A is the single largest importer with 2 shipments valued at $40.1K USD.

India's cyclophosphamide exports to Cuba are driven primarily by a handful of large-scale manufacturers. BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED with 3 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 4 active exporters signals a competitive but concentrated market — buyers in Cuba benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED, BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED , S.D.PHARMACEUTICALS — together account for 92% of total trade value on this route. The average shipment value of $13.2K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as cyclophosphamide 50mg 5x10 s tablet tax inv mh2511600099 dt 27 05 2025 and cyclophosphamide tablet 50mg ciclofosfam , suggesting that buyers in Cuba tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, MEDICUBA S A is the largest importer with 2 shipments worth $40.1K USD — representing 38% of all cyclophosphamide imports from India on this route. A total of 6 buyers are active on this corridor.